These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23514412)

  • 21. Preparation and in vitro and in vivo evaluation of quercetin-loaded mixed micelles for oral delivery.
    Lu Z; Bu C; Hu W; Zhang H; Liu M; Lu M; Zhai G
    Biosci Biotechnol Biochem; 2018 Feb; 82(2):238-246. PubMed ID: 29327653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery.
    Singh D; Rawat MS; Semalty A; Semalty M
    Curr Drug Discov Technol; 2012 Mar; 9(1):17-24. PubMed ID: 21644920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Casein nanoparticles in combination with 2-hydroxypropyl-β-cyclodextrin improves the oral bioavailability of quercetin.
    Peñalva R; Esparza I; Morales-Gracia J; González-Navarro CJ; Larrañeta E; Irache JM
    Int J Pharm; 2019 Oct; 570():118652. PubMed ID: 31472219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of biodegradable nanoparticles for delivery of quercetin.
    Kumari A; Yadav SK; Pakade YB; Singh B; Yadav SC
    Colloids Surf B Biointerfaces; 2010 Oct; 80(2):184-92. PubMed ID: 20598513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases.
    Wang Y; Tao B; Wan Y; Sun Y; Wang L; Sun J; Li C
    Biomed Pharmacother; 2020 Aug; 128():110372. PubMed ID: 32521458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles.
    Madhwi ; Kumar R; Kumar P; Singh B; Sharma G; Katare OP; Raza K
    Int J Pharm; 2017 Mar; 519(1-2):138-144. PubMed ID: 28093326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of glycyrrhetinic acid modification on preparation and evaluation of quercetin-loaded chitosan-based self-aggregates.
    Du H; Liu M; Yang X; Zhai G
    J Colloid Interface Sci; 2015 Dec; 460():87-96. PubMed ID: 26319324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus®/P407 micelles in diabetes treatment.
    Singh J; Mittal P; Vasant Bonde G; Ajmal G; Mishra B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S546-S555. PubMed ID: 30322273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
    Singh S; Kushwah V; Agrawal AK; Jain S
    Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption.
    Rumondor ACF; Dhareshwar SS; Kesisoglou F
    J Pharm Sci; 2016 Sep; 105(9):2498-2508. PubMed ID: 26886316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing quercetin bioavailability by super paramagnetic starch-based hydrogel grafted with fumaric acid: An in vitro and in vivo study.
    Doosti M; Seyed Dorraji MS; Mousavi SN; Rasoulifard MH; Hosseini SH
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110487. PubMed ID: 31518957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research and application of quercetin-loaded nano drug delivery system].
    Li SJ; Liao YF; Du Q
    Zhongguo Zhong Yao Za Zhi; 2018 May; 43(10):1978-1984. PubMed ID: 29933659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and prodrug studies of quercetin pentabenzensulfonate.
    Peng Y; Deng Z; Wang C
    Yakugaku Zasshi; 2008 Dec; 128(12):1845-9. PubMed ID: 19043305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
    Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermal quercetin smartCrystals®: Formulation development, antioxidant activity and cellular safety.
    Hatahet T; Morille M; Hommoss A; Dorandeu C; Müller RH; Bégu S
    Eur J Pharm Biopharm; 2016 May; 102():51-63. PubMed ID: 26948977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of human complement activation.
    Landi-Librandi AP; Chrysostomo TN; Caleiro Seixas Azzolini AE; Marzocchi-Machado CM; de Oliveira CA; Lucisano-Valim YM
    J Liposome Res; 2012 Jun; 22(2):89-99. PubMed ID: 22011316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-encapsulation of biodegradable nanoparticles with silicon quantum dots and quercetin for monitored delivery.
    Wang Q; Bao Y; Ahire J; Chao Y
    Adv Healthc Mater; 2013 Mar; 2(3):459-66. PubMed ID: 23184534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
    Tran TH; Guo Y; Song D; Bruno RS; Lu X
    J Pharm Sci; 2014 Mar; 103(3):840-52. PubMed ID: 24464737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.